Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals
Novel siRNA, Lepodisiran, Reduces Lipoprotein(a)
November 30, 2023
In the first-in-human phase 1 trial of lepodisiran, a novel short-interfering RNA (siRNA) therapy, levels of lipoprotein(a) (Lp(a)) were reduced below the lowest limit of quantitation for nearly nine months. Steven Nissen, MD, summarizes these findings th
A Cleveland Clinic podcast exploring heart, vascular and thoracic topics of interest to healthcare providers: medical and surgical treatments, diagnostic testing, medical conditions, and research, technology and practice issues.
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast